Goncharova N D, Mkhitarova L A
Probl Endokrinol (Mosk). 1993 Jan-Feb;39(1):51-4.
Time course of the major corticosteroid hormones and the precursors in the biosynthesis chain was studied, as was the type of corticosteroid complex formation with transcortin in the peripheral blood plasma in male papua hamadryas exposed to a 4-16 week infusions of LH releasing factor agonists (buserelin, Hoechst A. G., Germany, and surfagon, Cardiology Research Center of the Russian Academy of Medical Sciences) with the use of osmotic mini-pumps (Alza Corp., Palo Alto, USA). Suppression of the gonadal function resultant from prolonged infusion of LH releasing factor agonists was not associated with essential shifts in the adrenal steroidogenesis and in the specific corticosteroid transport. Such exposure induced a somewhat more marked activation of glucocorticoid and adrenal androgen secretion in response to acute stressor exposure (a single injection of insulin in a dose of 0.2 U/kg b. m.). One should bear in mind this fact when prescribing therapy with LH releasing factor agonists to patients with prostatic carcinoma, for the adrenal androgens are transformed into active androgens in the prostatic tissue.
研究了主要皮质类固醇激素及其生物合成链中前体的时间进程,以及雄性巴布亚狒狒外周血浆中皮质类固醇与皮质素转运蛋白形成复合物的类型。这些狒狒使用渗透微型泵(美国帕洛阿尔托的阿尔扎公司)接受了4至16周的促黄体生成素释放因子激动剂(布舍瑞林,德国赫斯特公司;以及舒法戈,俄罗斯医学科学院心脏病研究中心)输注。长期输注促黄体生成素释放因子激动剂导致的性腺功能抑制与肾上腺类固醇生成及特定皮质类固醇转运的本质变化无关。这种暴露在急性应激源暴露(单次注射剂量为0.2 U/kg体重的胰岛素)时,会引起糖皮质激素和肾上腺雄激素分泌更为明显的激活。在给前列腺癌患者开促黄体生成素释放因子激动剂治疗处方时应牢记这一事实,因为肾上腺雄激素在前列腺组织中会转化为活性雄激素。